Systemic hypoxia potentiates anti-tumor effects of metformin in hepatocellular carcinoma in mice.

This study supports that combination of systemic hypoxia and metformin treatment may represent a novel strategy for HCC.
PMID: 32250393 [PubMed - as supplied by publisher]

Source: Acta Biochimica et Biophysica Sinica - April 5, 2020 Category: Biochemistry Authors: Lin H, Zhou W, Huang Y, Ren M, Xu F, Wang H Tags: Acta Biochim Biophys Sin (Shanghai) Source Type: research